Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
10 When coadministered with a TZD, exenatide was associated with an 11% increased risk of hypoglycemia, compared with 7% for placebo
The STEP 1 trial demonstrated a mean body weight reduction of 14.9% at this dose after 68 weeks, with 86.4% of participants achieving at least 5% weight loss and 69 to 79% achieving 10% or more
Eli Lilly is banking on its experimental pill to entice potential users
Serious adverse events like pancreatitis and gallbladder disease are rare but documented, and semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma
US$ 21.25
US$ 20.27
US$ 21.08
US$ 23.96
US$ 24.36
US$ 20.79
